Miss Tace Conlin
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
Tace is a PhD Student undertaking her candidature within the Myeloma Research Laboratory and the Supportive Oncology Research Group, at the South Australian Health and Medical Research Institute (SAHMRI). Her research focuses on modulating the blood-brain barrier to optimise drug delivery and therapeutic outcomes for the treatment of debilitating brain cancers/diseases, with a specific interest in paediatric oncology.
This research aims to increase patient quality of life, and extend the overall survival of patients with devastating CNS diseases.
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2025 | Scholarship | Lady Barr Smith Scholarship in Cancer Research | The University of Adelaide | Australia | - |
| Year | Citation |
|---|---|
| 2023 | Eadie, L. N., Schutz, C. E., Page, E. C., Conlin, T. S., Heatley, S. L., Lagonik, E., . . . White, D. L. (2023). Asciminib Is Effective Against ABL1 Gene Fusions in Acute Lymphoblastic Leukemia but Only When the ABL1 SH3 Domain Is Present. In BLOOD Vol. 142 (pp. 4 pages). CA, San Diego: AMER SOC HEMATOLOGY. DOI WoS4 |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2025 - ongoing | President | SAHMRI Student Association Committee | SAHMRI | Australia |
| 2024 - 2025 | Member | SAHMRI Student Association Committee | SAHMRI | Australia |
| 2022 - 2023 | Member | Adelaide Protein Group (APG) | The University of Adelaide | Australia |
| Date | Title | Engagement Type | Institution | Country |
|---|---|---|---|---|
| 2022 - 2022 | Seoul-Changing Biotechnology Study Tour | Scientific Community Engagement | The University of Adelaide | Korea, Republic of |